The New York Times @nytimes
Buprenorphine, a once highly restricted medication to treat opioid addiction, is now available to far more U.S. doctors thanks to significant policy change. But problems around training and access could stall efforts to get people the drug, experts say. https://t.co/Xcge7uce5z — PolitiTweet.org